Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03947073 · ClinicalTrials.gov registry record · NA
Gestation Diabetes N'Teractive Media-based Education (GDnME)
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 199
- Enrollment target
NCT03947073: Completed NA study, sponsored by Columbia University.
NCT03947073 is a NA study that has completed, run by Columbia University. The registered enrollment target is 199 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03947073, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
Study Summary
This study is a prospective randomized controlled trial. Subjects with newly diagnosed gestational diabetes will be randomized to either standard of care diabetes education versus standard of care plus an interactive educational application.
Primary Outcome
This is defined as a patient who is unable to adequately control blood sugars with diet alone and requires medical intervention. This information will be collected until the time of delivery which could be up to 42 weeks of gestation.
Interventions
- OTHER Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2021-01-27 |
| Phase | NA |
What the finished NCT03947073 record still lists
NCT03947073 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Education is the first listed.
NCT03947073 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03947073 about?
NCT03947073 is a clinical study titled "Gestation Diabetes N'Teractive Media-based Education (GDnME)". This study is a prospective randomized controlled trial. Subjects with newly diagnosed gestational diabetes will be randomized to either standard of care diabetes education versus standard of care plus an interactive educational application.
What is the current status of trial NCT03947073?
This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2019-06-12. Estimated completion is 2021-01-27.
What interventions are being tested in trial NCT03947073?
The interventions under investigation include: Education (OTHER).
Who is sponsoring clinical trial NCT03947073?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03947073's enrollment target sits among peer trials
199 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI